Toxicités cutanées à l’enfortumab védotine : expérience dans un centre expert
S. Oro, M. Aubert, V. Sibaud, A. Perego-Langlais et autres
0 citationsAnnales de Dermatologie et de Vénéréologie - FMC
Carolina Saldana
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
43Publications signalées
447Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Renal cell carcinoma treatmentProstate Cancer Treatment and ResearchBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersRenal and related cancers
Publications récentes
Effects of cardiologic magnetic and optical stimulation on quality of life in patients receiving systemic treatment for cancer: a pilot study
Maamoun Ben Cheikh, Nadia Volf, Carolina Saldana, Daniela Dau et autres
1 citationElectromagnetic Biology and Medicine
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial
Stéphane Oudard, Yohann Tran, Carole Hélissey, Charles Vauchier et autres
1 citationEuropean Urology Oncology
Pain and Health-Related Quality of Life with Two-Weekly vs Three-Weekly Cabazitaxel Schedule in Older Men with Metastatic Castration-Resistant Prostate Cancer (CABASTY): An Open-Label, Randomized, Phase 3 Trial
Stéphane Oudard, Yohann Tran, Carole Hélissey, Raffaele Ratta et autres
0 citationsSSRN Electronic Journal
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
Christian Pfister, Gwénaëlle Gravis, Aude Fléchon, Christine Chevreau et autres
111 citationsThe Lancet Oncology
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer
Stéphane Oudard, Raffaele Ratta, Éric Voog, Philippe Barthélémy et autres
23 citationsJAMA Oncology
Skin toxicity of enfortumab vedotin: Proposal of a specific management algorithm
Yannick S. Elshot, Sònia Segura, A. Marchand, Damien Pouessel et autres
13 citationsJournal of the European Academy of Dermatology and Venereology
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study
E. Baudry, Natacha Naoun, Édouard Auclin, Carolina Saldana et autres
4 citationsEuropean Journal of Cancer
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA
Émeline Colomba, Sarah Flora Jonas, Jean‐Christophe Eymard, R. Delva et autres
19 citationsEuropean Urology
Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study
Yazid Belkacémi, Gabriele Coraggio, Anne Brunel, A. Jouhaud et autres
3 citationsAdvances in Radiation Oncology
Leukocyte subtypes and myeloid derived suppressor cells as prognostic markers in metastatic castration resistant prostate cancer treated with cabazitaxel: A satellite study of the CABASTY phase III trial.
Jean-David Heisbourg, Stéphane Oudard, Philippe Beuzeboc, Mostefa Bennamoun et autres
0 citationsJournal of Clinical Oncology
Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells
Amene Majidipur, Margot Morin‐Dewaele, Jeanne Gaspar Lopes, François Berry et autres
3 citationsInternational Journal of Molecular Sciences
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.